Last Posted: Jan 02, 2019
- Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci.
Witoelar Aree et al. Scientific reports 2018 Dec (1) 18088 - Radiogenomics for Precision Medicine With A Big Data Analytics Perspective.
Panayides Andreas S et al. IEEE journal of biomedical and health informatics 2018 Dec - APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease.
El Shamieh Said et al. Personalized medicine 2018 - Direct-To-Consumer Genetic Testing: Is the Public Ready for Simple, At-Home DNA Tests to Detect Disease Risk?
Bates Mary et al. IEEE pulse 9(6) 11-14 - Biobank-wide association scan identifies risk factors for late-onset Alzheimer's disease and endophenotypes
D Yan et al, BiorxIV preprints, November 12, 2018 - Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
Marshe Victoria S et al. Journal of neural transmission (Vienna, Austria : 1996) 2018 Oct - Alzheimer's Disease and Healthy Aging
CDC Information, 2018 - Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers.
Sapkota Shraddha et al. Frontiers in aging neuroscience 2018 10296 - Development, application, and results from a precision-medicine platform that personalizes multi-modal treatment plans for mild Alzheimer's disease and at-risk individuals.
Keine Dorothy et al. Current aging science 2018 Oct - Does genetic risk for common adult diseases influence reproductive plans? Evidence from a national survey experiment in the United States.
Pinar Candas et al. Social science & medicine (1982) 2018 Sep 21862-68
.png)
No hay comentarios:
Publicar un comentario